Most conventional antitumor necrosis factor (TNF) medications have been documented to cause ILD, including infliximab, etanercept, adalimumab, golimumab, certolizumab pegol, and the IL‐6 receptor (IL‐6R) antagonist tocilizumab.34, 35, 36. This evidence concerns the gene IL6R and interstitial lung disease.